Trial Profile
A Phase I Safety, Dose Escalating Study of MultiGeneAngio in Patients With Peripheral Arterial Disease
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 27 Nov 2016
Price :
$35
*
At a glance
- Drugs MultiGeneAngio (Primary)
- Indications Peripheral arterial disorders
- Focus Adverse reactions
- Sponsors MultiGene Vascular Systems
- 02 May 2014 New trial record